These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15438043)

  • 21. [Action of streptomycin and sodium paraminosalicylate in experimental tuberculosis in a guinea pig].
    MARAL R; BLANDIN A
    Ann Inst Pasteur (Paris); 1950 May; 78(5):677-81. PubMed ID: 15425955
    [No Abstract]   [Full Text] [Related]  

  • 22. Pulmonary tuberculosis treated with streptomycin and para-amino-salicylic acid.
    MURTY GS
    Antiseptic; 1950 Jan; 47(1):61-3. PubMed ID: 15409636
    [No Abstract]   [Full Text] [Related]  

  • 23. [Bacteriostatic effect of streptomycin, PAS, salicylic acid, para-aminobenzoic acid, calciferol and nitrogranulogen on tuberculosis bacilli].
    SLOPEK S
    Med Dosw Mikrobiol; 1950; 2(2):231-2. PubMed ID: 14815337
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative value of streptomycin and paraaminosalicylic acid in pulmonary tuberculosis therapy].
    FASANO E; TAROZZI L
    Minerva Med; 1950 May; 41(23):786-7. PubMed ID: 15423280
    [No Abstract]   [Full Text] [Related]  

  • 25. [Streptomycin resistance and PAS resistance].
    VUGA D
    Minerva Pediatr; 1950 Apr; 2(4):170-2. PubMed ID: 15423311
    [No Abstract]   [Full Text] [Related]  

  • 26. Para-amino-salicylic acid with streptomycin in pulmonary tuberculosis.
    LEWIN N; ARONOVITCH M
    Can Med Assoc J; 1951 Aug; 65(2):140-4. PubMed ID: 14859165
    [No Abstract]   [Full Text] [Related]  

  • 27. The combined effect of streptomycin and para-aminosalicylic acid on experimental tuberculosis in mice.
    YOUMANS GP; YOUMANS AS; OSBORNE RR
    J Lancet; 1947 Nov; 67(11):403. PubMed ID: 20269417
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of pulmonary tuberculosis on a combined regimen of para-amino-salicylic acid, streptomycin and isonicotinic acid hydrazide.
    KUMAGAI T; OKA S; SUZUKI C; KUROBANE T; KANNO I; SATO S; NIITU Y; AWATAGUCHI S; UEDA H; YAMADA S; YAKUWA E; SUGAWARA T; SHOJI M; KANAYA A; KOMATSUDA K
    Sci Rep Res Inst Tohoku Univ Med; 1956 Mar; 6(4):401-32. PubMed ID: 13337367
    [No Abstract]   [Full Text] [Related]  

  • 29. [In vitro effect of various substances on Mycobacterium tuberculosis. I. Titration of streptomycin, aureomycin, PAS, caffeic acid, 5-nitro-2-furaldehyde-semicarbazone and salicylic acid in Dubos medium].
    TERNI M; ZANELLI QUARANTINI MG
    Boll Ist Sieroter Milan; 1951; 30(11-12):689-702. PubMed ID: 14934836
    [No Abstract]   [Full Text] [Related]  

  • 30. [In vitro activity of various substance on Mycobacterium tuberculosis. II. Streptomycin aureomycin, PAS, caffeic acid, 5-nitro-2-furaldehyde-semicarbazone and salicylic acid; mechanism of action with reference to bacterial resistance].
    TERNI M; ZANELLI QUARANTINI MG
    Boll Ist Sieroter Milan; 1952; 31(1-2):55-74. PubMed ID: 14934844
    [No Abstract]   [Full Text] [Related]  

  • 31. A preliminary report on the use of para-amino salicylic acid in the treatment of pulmonary tuberculosis.
    SWEANY HC; TURNER GC
    Dis Chest; 1949 Dec; 16(6):633-60, illust. PubMed ID: 15396512
    [No Abstract]   [Full Text] [Related]  

  • 32. Para-aminosalicylic acid (PAS) in chronic pulmonary tuberculosis.
    DOONEIEF AS; BUCHBERG A; STEINBACH MM
    N Engl J Med; 1950 Jun; 242(22):859-62. PubMed ID: 15416913
    [No Abstract]   [Full Text] [Related]  

  • 33. [Central and peripheral hematological modifications in the course of treatment with streptomycin and p-aminosalicylic acid].
    SCARPA A; LONGO P
    Policlinico Prat; 1950 May; 57(21):688-94. PubMed ID: 15440359
    [No Abstract]   [Full Text] [Related]  

  • 34. [Variations of prothrombin level during the treatment of paraaminosalicylic acid].
    CONGIU M; LEO P
    Rass Med Sarda; 1952; 54(7-8):193-7. PubMed ID: 13014342
    [No Abstract]   [Full Text] [Related]  

  • 35. [Action of p-aminosalicylic acid on the prothrombin and thromboplastin level in pulmonary tuberculosis].
    MARRA A
    Arch Tisiol Mal Appar Respir; 1950 Apr; 5(4):341-4. PubMed ID: 14777683
    [No Abstract]   [Full Text] [Related]  

  • 36. Experimental and clinical investigations on para-amino-salicylic acid (pas)--alone or in association with streptomycin--in ocular tuberculosis.
    GUNDERSEN T; BIETTI GB
    Trans Am Ophthalmol Soc; 1949; 47():276-300. PubMed ID: 15418600
    [No Abstract]   [Full Text] [Related]  

  • 37. [PAS in the treatment of pleuropulmonary tuberculosis].
    STICOTTI S; BARBIERO F
    Lotta Tuberc; 1950; 20(3-4):173-84. PubMed ID: 15438005
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparative study of the effects of para-amino salicylic acid and thephorin on the emergence of streptomycin resistant Salmonella.
    FROMBERG V
    Am J Pharm Sci Support Public Health; 1951 Apr; 123(4):116-22. PubMed ID: 14838103
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of tuberculosis with paraaminosalicylic acid].
    LEITNER SJ; MASSON P
    Schweiz Med Wochenschr; 1950 Apr; 80(15):375-85. PubMed ID: 15413136
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pulmonary tuberculosis and therapy with streptomycin-PAS-sulfone].
    BOUCHER H; DARBON ; STEIGER ; PRAT ; GUILLERMAND
    Lyon Med; 1950 Apr; 183(18):277-81. PubMed ID: 15416201
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.